Detalhe da pesquisa
1.
Models using comprehensive, lesion-level, longitudinal [68Ga]Ga-DOTA-TATE PET-derived features lead to superior outcome prediction in neuroendocrine tumor patients treated with [177Lu]Lu-DOTA-TATE.
Eur J Nucl Med Mol Imaging;
2024 May 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38795121
2.
Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study.
Lancet Oncol;
24(5): 496-508, 2023 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37142372
3.
Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-expansion stage of a multicentre, open-label, phase I trial.
Br J Cancer;
129(5): 797-810, 2023 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37474720
4.
Ampullary Adenocarcinoma, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw;
21(7): 753-782, 2023 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37433437
5.
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study.
Lancet;
398(10302): 759-771, 2021 08 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34454674
6.
A phase I study of the anaplastic lymphoma kinase inhibitor ceritinib in combination with gemcitabine-based chemotherapy in patients with advanced solid tumors.
Int J Cancer;
149(12): 2063-2074, 2021 12 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34319586
7.
Targeting the NTRK Fusion Gene in Pancreatic Acinar Cell Carcinoma: A Case Report and Review of the Literature.
J Natl Compr Canc Netw;
19(1): 10-15, 2021 01 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33406492
8.
Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw;
19(4): 439-457, 2021 04 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33845462
9.
Multicenter phase 2 trial of nintedanib in advanced nonpancreatic neuroendocrine tumors.
Cancer;
126(16): 3689-3697, 2020 08 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32525561
10.
A multicentre phase 1b/2 study of tivozanib in patients with advanced inoperable hepatocellular carcinoma.
Br J Cancer;
122(7): 963-970, 2020 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32037403
11.
Pancreatic Adenocarcinoma, Version 1.2019.
J Natl Compr Canc Netw;
17(3): 202-210, 2019 03 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30865919
12.
A phase 1, open-label, dose escalation study of intravenous paricalcitol in combination with gemcitabine in patients with advanced malignancies.
Cancer;
124(19): 3890-3899, 2018 10 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30299542
13.
Multi-gene Panel Testing in Breast Cancer Management.
Cancer Treat Res;
173: 121-140, 2018.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29349761
14.
Risks and benefits of phase I liver dysfunction studies: should patients with severe liver dysfunction be included in these trials?
Invest New Drugs;
35(3): 386-391, 2017 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28102465
15.
A phase I/II study of nintedanib and capecitabine for refractory metastatic colorectal cancer.
JNCI Cancer Spectr;
8(3)2024 Apr 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38697618
16.
Results of a Randomized, Double-Blind, Placebo-Controlled, Phase 1b/2 Trial of Nabpaclitaxel + Gemcitabine ± Olaratumab in Treatment-Naïve Participants with Metastatic Pancreatic Cancer.
Cancers (Basel);
16(7)2024 Mar 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38611000
17.
A synergistic two-drug therapy specifically targets a DNA repair dysregulation that occurs in p53-deficient colorectal and pancreatic cancers.
Cell Rep Med;
5(3): 101434, 2024 Mar 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38387463
18.
Sugar Sweetened and Artificially Sweetened Beverage Consumption and Pancreatic Cancer: A Retrospective Study.
Nutrients;
15(2)2023 Jan 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36678146
19.
Role of the DEAD-box RNA helicase DDX5 (p68) in cancer DNA repair, immune suppression, cancer metabolic control, virus infection promotion, and human microbiome (microbiota) negative influence.
J Exp Clin Cancer Res;
42(1): 213, 2023 Aug 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37596619
20.
Evaluation of the serotonin pathway as a biomarker in cholangiocarcinoma.
J Gastrointest Oncol;
14(5): 2192-2201, 2023 Oct 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37969829